Reuters logo
BRIEF-OMEROS ANNOUNCES SETTLEMENT OF INFRINGEMENT SUIT AGAINST ANDA FILER PAR
October 5, 2017 / 3:13 PM / 17 days ago

BRIEF-OMEROS ANNOUNCES SETTLEMENT OF INFRINGEMENT SUIT AGAINST ANDA FILER PAR

Oct 5 (Reuters) - Omeros Corp:

* OMEROS ANNOUNCES SETTLEMENT OF INFRINGEMENT SUIT AGAINST ANDA FILER PAR

* ENTERED INTO A SETTLEMENT AGREEMENT WITH PAR PHARMACEUTICAL, INC. AND ITS SUBSIDIARY RESOLVING OMEROS’ PATENT LITIGATION AGAINST PAR​

* UNDER SETTLEMENT, PAR TO PAY TO CO ROYALTY OF 15% OF PAR‘S NET SALES OF ANY GENERIC VERSION OF OMIDRIA UNTIL LATEST EXPIRATION OF PATENTS

* ‍LAST-TO-EXPIRE OF OMEROS’ ORANGE BOOK LISTED PATENTS FOR OMIDRIA EXPIRES ON OCTOBER 23, 2033​

* UNLESS SUBSEQUENTLY AUTHORIZED IN SETTLEMENT AGREEMENT, PAR WILL BE PROHIBITED FROM LAUNCHING GENERIC VERSION OF OMIDRIA UNTIL APRIL 1, 2032 Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below